Estimating Design Effect and Calculating Sample Size for Respondent-Driven Sampling Studies of Injection Drug Users in the United States

被引:97
作者
Wejnert, Cyprian [1 ]
Huong Pham [2 ]
Krishna, Nevin [1 ]
Le, Binh [1 ]
DiNenno, Elizabeth [1 ]
机构
[1] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA
[2] ICF Int, Atlanta, GA USA
关键词
Respondent-driven sampling; Design effect; Sample size; Injecting drug users; HIV; Hidden populations; BEHAVIORAL SURVEILLANCE; HIV; PREVALENCE; VARIANCE;
D O I
10.1007/s10461-012-0147-8
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Respondent-driven sampling (RDS) has become increasingly popular for sampling hidden populations, including injecting drug users (IDU). However, RDS data are unique and require specialized analysis techniques, many of which remain underdeveloped. RDS sample size estimation requires knowing design effect (DE), which can only be calculated post hoc. Few studies have analyzed RDS DE using real world empirical data. We analyze estimated DE from 43 samples of IDU collected using a standardized protocol. We find the previous recommendation that sample size be at least doubled, consistent with DE = 2, underestimates true DE and recommend researchers use DE = 4 as an alternate estimate when calculating sample size. A formula for calculating sample size for RDS studies among IDU is presented. Researchers faced with limited resources may wish to accept slightly higher standard errors to keep sample size requirements low. Our results highlight dangers of ignoring sampling design in analysis.
引用
收藏
页码:797 / 806
页数:10
相关论文
共 27 条
[1]  
[Anonymous], 1965, Survey sampling
[2]  
[Anonymous], RESPONDENT DRIVEN SA
[3]   AIDS-PREVENTION OUTREACH AMONG INJECTION-DRUG USERS - AGENCY PROBLEMS AND NEW APPROACHES [J].
BROADHEAD, RS ;
HECKATHORN, DD .
SOCIAL PROBLEMS, 1994, 41 (03) :473-495
[4]  
CDC, 2009, 20092011 CDC, V21
[5]  
CORNFIELD J, 1951, AM J PUBLIC HEALTH, V41, P654
[6]   Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City [J].
Des Jarlais, Don C. ;
Arasteh, Kamyar ;
Perlis, Theresa ;
Hagan, Holly ;
Abdul-Quader, Abu ;
Heckathorn, Douglas D. ;
McKnight, Courtney ;
Bramson, Heidi ;
Nemeth, Chris ;
Torian, Lucia V. ;
Friedman, Samuel R. .
AIDS, 2007, 21 (02) :231-235
[7]   Behavioral surveillance among people at risk for HIV infection in the US: The National HIV Behavioral Surveillance System [J].
Gallagher, Kathleen M. ;
Sullivan, Patrick S. ;
Lansky, Amy ;
Onorato, Ida M. .
PUBLIC HEALTH REPORTS, 2007, 122 :32-38
[8]   Improved Inference for Respondent-Driven Sampling Data With Application to HIV Prevalence Estimation [J].
Gile, Krista J. .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2011, 106 (493) :135-146
[9]   Assessing respondent-driven sampling [J].
Goel, Sharad ;
Salganik, Matthew J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (15) :6743-6747
[10]   Respondent-driven sampling II: Deriving valid population estimates from chain-referral samples of hidden populations [J].
Heckathorn, DD .
SOCIAL PROBLEMS, 2002, 49 (01) :11-34